Related Articles

• The XIAP inhibitor embelin sensitises malignant rhabdoid tumour cells to TRAIL treatment via enhanced activation of the extrinsic apoptotic pathway
• Pre-activation of the p53 pathway through Nutlin-3a sensitises sarcomas to drozitumab therapy
• Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment
• The Chk1 inhibitor AZD7762 sensitises p53 mutant breast cancer cells to radiation in vitro and in vivo
• Zoledronic acid re‑sensitises gefitinib‑resistant lung cancer cells by inhibiting the JAK/STAT3 signalling pathway and reversing epithelial‑mesenchymal transition